Nick Shah

Scientist | Commercialization, Drug Discovery

Role: Scientist

Site: CDL-West

Stream: Health

Nick is a scientist and leader with extensive experience in leading cross-functional technical teams that build tools to interrogate difficult drug targets. He currently leads the Assay Science efforts at DiCE Molecules where the team is working to leverage chemical evolution in small molecule drug discovery. Prior to DiCE, Nick was a very early scientist at Flexus Biosciences / FLX Bio and helped discover two molecules that are currently in clinical testing for cancer immunotherapy: BMS-986205 in multiple Phase II trials & FLX475 in Phase I. Throughout his career, Nick has been deeply involved in assay development for drug discovery while leading project teams and managing multiple large-scale screening campaigns.